Search - tctmd.com

Displaying 121 - 140 of 482

Sort: Relevancy | Date

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Prosthetic Valve Endocarditis After Transcatheter and Surgical Aortic Valve Replacement: Analysis of the Society of Thoracic Surgeons Database

Presenter: Shinichi Fukuhara

June 09, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Todd Neale

March 16, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

Advertisement

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Prosthetic Valve Endocarditis After Transcatheter and Surgical Aortic Valve Replacement: Analysis of the Society of Thoracic Surgeons Database

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

As TAVI Turns 20, How Has the Heart Team Evolved?

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content